| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | — | 1 | 2 | — | 1 | 6 | 5 | 1 | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.60 |
—
—
—
|
| 2025 | 0.54 |
—
—
—
—
|
| 2024 | 0.50 |
—
—
—
—
|
| 2023 | 0.48 |
—
—
—
—
|
| 2022 | 0.44 |
—
—
—
—
|
| 2021 | 0.26 |
—
—
—
—
|
| 2020 | 0.16 |
—
—
|
| 2019 | 0.15 |
—
|
| 2018 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 398.80 | 690.00 | 848.80 | 977.80 |
| Receivables | 752.70 | 710.00 | 774.70 | 586.20 |
| Inventory | 1,290.10 | 1,131.30 | 1,237.70 | 1,157.60 |
| Other | 196.00 | 319.80 | 292.50 | 245.30 |
| 2,637.60 | 2,851.10 | 3,153.70 | 2,966.90 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 567.90 | 663.40 | 597.60 | 598.50 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 1,787.50 | 2,010.50 | 2,032.50 | 1,853.20 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Feb | May | Aug | Nov | Year | |
|---|---|---|---|---|---|
| ’26 | 1,742.50 | 1,562.00 | — | — |
—
|
| ’25 | 1,526.80 | 1,446.00 | 1,543.40 | 1,765.80 |
6,282.00
|
| ’24 | 1,480.20 | 1,358.80 | 1,443.10 | 1,749.90 |
6,032.00
|
| ’23 | 1,688.90 | 1,336.80 | 1,511.00 | 1,305.40 |
5,842.10
|
| ’22 | 1,591.60 | 1,471.10 | 1,517.20 | 1,588.70 |
6,168.60
|
| ’21 | 1,305.60 | 1,275.97 | 1,497.58 | 1,684.75 |
5,763.90
|
| ’20 | 1,506.13 | 497.54 | 1,063.09 | 1,385.85 |
4,452.60
|
| Feb | May | Aug | Nov | Year | |
|---|---|---|---|---|---|
| ’26 | 211.50 | 270.80 | — | — |
—
|
| ’25 | 52.50 | 185.50 | 24.80 | 266.80 |
529.60
|
| ’24 | 286.00 | 262.80 | 52.30 | 297.30 |
898.40
|
| ’23 | (160.80) | 286.20 | 51.20 | 258.90 |
435.50
|
| ’22 | 86.10 | 59.80 | 64.40 | 17.80 |
228.10
|
| ’21 | 69.48 | 178.54 | 250.83 | 238.45 |
737.30
|
| ’20 | 197.88 | (156.52) | 199.50 | 228.74 |
469.60
|
| Feb | May | Aug | Nov | Year | |
|---|---|---|---|---|---|
| ’26 | 152.10 | 230.90 | — | — |
—
|
| ’25 | (14.10) | 168.30 | (39.30) | 216.40 |
331.30
|
| ’24 | 214.40 | 222.60 | 2.30 | 231.60 |
670.90
|
| ’23 | (271.70) | 215.70 | (17.80) | 195.70 |
121.90
|
| ’22 | 12.50 | 12.90 | (11.90) | (52.50) |
(39.00)
|
| ’21 | 32.49 | 148.02 | 209.90 | 179.98 |
570.40
|
| ’20 | 153.46 | (187.30) | 185.22 | 187.82 |
339.20
|
| Feb | May | Aug | Nov | Year | |
|---|---|---|---|---|---|
| ’26 | 0.45 | 0.22 | — | — |
—
|
| ’25 | 0.34 | 0.17 | 0.55 | 0.40 |
1.45
|
| ’24 | (0.03) | 0.04 | 0.05 | 0.46 |
0.52
|
| ’23 | 0.29 | 0.00 | 0.02 | 0.32 |
0.62
|
| ’22 | 0.48 | 0.12 | 0.43 | 0.38 |
1.41
|
| ’21 | 0.35 | 0.16 | 0.47 | 0.37 |
1.35
|
| ’20 | 0.37 | (0.91) | 0.07 | 0.14 |
(0.32)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 13.57 | 12.42 | 14.87 | 12.17 | — | — | — |
Low Price
|
| — | — | — | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.25 | 19.36 | 24.34 | 24.82 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18,000 | 19,100 | 18,700 | 19,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.34 | 0.31 | 0.32 | 0.33 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,168.60 | 5,842.10 | 6,032.00 | 6,282.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 57.53% | 57.53% | 60.63% | 61.73% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 649.60 | 266.30 | 217.60 | 634.00 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.53% | 4.56% | 3.61% | 10.09% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 569.10 | 249.60 | 210.60 | 578.10 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 170.50 | 255.50 | 310.10 | 208.80 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.52 | 14.71 | 15.15 | 15.88 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 1.43 | 0.63 | 0.53 | 1.46 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.57 | 1.10 | 2.26 | 1.34 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.67) | (0.79) | (0.57) | (0.50) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.10) | 0.31 | 1.68 | 0.84 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.79 | 5.15 | 4.95 | 5.76 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 397.34 | 397.21 | 398.23 | 395.53 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 11.48 | 24.59 | 34.30 | 15.27 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.06 | 1.05 | 1.20 | 1.40 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.45 | 3.01 | 3.67 | 3.87 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.18 | 1.21 | 1.30 | 1.48 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (187.16) | 57.77 | 11.66 | 28.03 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 228.10 | 435.50 | 898.40 | 529.60 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (267.10) | (313.60) | (227.50) | (198.30) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (39.00) | 121.90 | 670.90 | 331.30 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 846.30 | 850.10 | 840.60 | 1,121.20 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,231.50 | 1,009.40 | 994.00 | 1,039.20 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 731.30 | 610.60 | 304.00 | 190.40 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,903.70 | 2,046.40 | 1,970.50 | 2,278.60 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.53% | 4.13% | 3.39% | 8.74% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.33% | 8.34% | 7.22% | 17.15% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.89% | 12.64% | 10.49% | 27.21% | ‡‡‡‡‡ | — | — |
ROE
|
Levi Strauss & Co. (LEVI) demonstrates resilient fundamentals amid apparel sector headwinds, with revenue growing at a 3.4% CAGR from $4.55 billion in 2016 to $6.03 billion in 2024, rebounding sharply post-COVID via a DTC pivot now over 40% of sales. Gross margins have expanded dramatically from 51.2% to a projected 61.7% by 2025, driven by pricing power and efficiencies, while EPS is forecast to surge 370% to $2.51 by 2028. Analysts project revenue acceleration to $7.49 billion by 2028 and price targets implying 5% to 51% upside, underscoring undervaluation at current levels with a forward P/E compressing to ~9x.
A fortress balance sheet bolsters this outlook: debt slashed 45% to $994 million, equity up 52%, and robust FCF supporting dividends and buybacks. Stock performance has mirrored these trends—from $9.09 lows in 2020 to $30.84 highs in 2021—yet trades 23% below mean targets amid moderating inflation and DTC tailwinds.
Insider selling persists without offsetting buys, alongside risks from geopolitics and consumer slowdowns, but Levi’s brand moat and sustainability push position it for premium denim dominance—making it a compelling recovery play worth deeper exploration.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.